- 1001. ActInvoiceRootGroupCode
- [Type of invoice element that is used to assist in describing an Invoice that is either submitted for adjudication or for which is returned on adjudication results. Invoice elements of this type signify a grouping of one or more children (detail) invoice elements. They do not have intrinsic costing associated with them, but merely reflect the sum of all costing for it's immediate children invoice elements.Codes from this domain reflect the type of Invoice such as Pharmacy Dispense, Clinical Service and Clinical Product. The domain is only specified for the root (top level) invoice element group for an Invoice. ( HL7V3.0 )] (UMLS (HL7) C1699087) =Intellectual Product =ActInvoiceGroupCode;
=oral health service;
clinical service invoice;
clinical product invoice;
financial invoice;
sessional or block fee invoice;
Rx compound invoice;
Rx dispense invoice;
preferred accommodation invoice;
vision dispense invoice;
clinical service and product | - 1051. Active Transcription Factor CREB
- [Encoded as alternative A, B isoforms by human CREB1 Gene (bZIP/CREB Family), nuclear cAMP Responsive Element Binding Protein 1 is a homodimeric transcription factor containing 1 KID domain, phosphorylated/stimulated by several protein kinases, that binds to octameric DNA palindrome cAMP-response elements (CRE) present in many viral and cellular promoters and induces gene transcription in response to hormonal stimulation of the cAMP pathway. (NCI) ( NCI )] (UMLS (NCI) C1447703) cAMP Responsive Element Binding Protein 1;
CREB1;
Transactivator Protein;
=Amino Acid, Peptide, or Protein; Biologically Active Substance |
- 1002. action
- [Sender asks addressee to do something depending on the focal Act of the payload. An example is "fulfill this order". Addressee has responsibilities to either reject the message or to act on it in an appropriate way (specified by the specific receiver responsibilities for the interaction). ( HL7V3.0 )] (UMLS (HL7) C1552007) =Idea or Concept =control act;
| - 1052. active transport
- [any ATP-driven cellular process for moving solutes or organelles; e.g., ATPase transmembrane pumps, pinocytosis and related membrane flux events, cytoskeletal rearrangements; contrast with PASSIVE TRANSPORT. ( CSP )] (UMLS (CSP) C0005529) =Physiologic Function ;
|
- 1003. Action
- [A thing done. ( NCI )] (UMLS (NCI) C0441472) =Functional Concept
| - 1053. Active Transporter Interaction
- [Active Transporter Interaction involves temporary non-covalent binding of a molecule through intermolecular physical forces of attraction with a protein that, after conformational change, moves a bound substrate across a cell membrane with (symport) or against (antiport) a concentration gradient resulting directly from the expenditure of energy. ( NCI )] (UMLS (NCI) C1373104) Active Transporter Interactions =Molecular Function =Receptor Interactions;
=Neurotransmitter Transporter Interactions;
ATP-Binding Cassette (ABC) Transporter Interactions;
Organic Anion Transporter Interactions;
Small Ion Transport Pump Interactions |
- 1004. Action Code
- (UMLS (HL7) C1547718) =Intellectual Product =HL7 Vocabulary Version 2.5;
=Add/Insert;
Delete;
Update;
No change | - 1054. Active _ Consent has been granted
- (UMLS (HL7) C1548942) =Idea or Concept =Consent Status;
|
- 1005. action potential
- [a rapid self-propagating change in the electrical potential across a neuron, gland, or muscle fiber membrane primarily due to a sudden influx of sodium ions followed by an efflux of potassium ions. ( CSP )] (UMLS (CSP) C0001272) =Cell Function ;
| - 1055. Active/Inactive
- (UMLS (HL7) C1547601) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Active Staff;
Inactive Staff;
|
- 1006. Action Taken in Response to the Event
- (UMLS (HL7) C1547656) =Idea or Concept =HL7 Vocabulary Version 2.5;
=Product dose or frequency of use increased;
Product dose or frequency of use reduced;
Product withdrawn permanently;
Product withdrawn temporarily;
Other;
None | - 1056. Active/Valid
- (UMLS (HL7) C1549073) =Idea or Concept =Certificate Status;
|
- 1007. ACTIV MUSCULOSK EXER NEC
- [ ] (UMLS (ICD9CM) C0178012) =Therapeutic or Preventive Procedure
| - 1057. ActiveIngredientDrugEntityType
- [Any substance which, when combined with other ingredients, delivers all or part of the therapeutic benefit associated with a medication. ( HL7V3.0 )] (UMLS (HL7) C1698554) =Intellectual Product =ClinicalDrug;
|
- 1008. Activase
- (UMLS (NCI) C0701942) =Amino Acid, Peptide, or Protein; Pharmacologic Substance; Enzyme ;
| - 1058. Activin
- [produced in the pituitary, gonads, and other tissues; by acting locally, they stimulate pituitary FSH secretion and have diverse effects on cell differentiation and embryonic development. ( CSP )] (UMLS (NCI) C0050668) =Amino Acid, Peptide, or Protein; Hormone ;
=Peptide Hormone;
|
- 1009. activated aminoacid
- [ ] (UMLS (CSP) C0599000) =Amino Acid, Peptide, or Protein ;
| - 1059. ActiVin
- (UMLS (NCI) C1135154) =Organic Chemical; Pharmacologic Substance ;
|
- 1010. Activated Hepatocyte Growth Factor Receptor Gene
- [The MET oncogene is derived from a chromosomal rearrangement involving the MET and TPR (translocated promoter region) loci and is a cloned gene for Hereditary Papillary Renal Carcinoma. The MET proto-oncogene encodes hepatocyte growth factor receptor, a disulfide-linked two subunit receptor protein tyrosine kinase. The human gene is located at 7q31. ( NCI )] (UMLS (NCI) C1417123) Hepatocyte Growth Factor Receptor Gene;
MET;
MET Gene;
Met Proto-Oncogene (Hepatocyte Growth Factor Receptor) Gene;
Oncogene HGFR;
Oncogene MET =Gene or Genome | - 1060. Activin A
- [The inhibin beta A subunit joins the alpha subunit to form a pituitary FSH secretion inhibitor. Inhibin has been shown to regulate gonadal stromal cell proliferation negatively and to have tumor-suppressor activity. In addition, serum levels of inhibin have been shown to reflect the size of granulosa-cell tumors and can therefore be used as a marker for primary as well as recurrent disease. Because expression in gonadal and various extragonadal tissues may vary severalfold in a tissue-specific fashion, it is proposed that inhibin may be both a growth/differentiation factor and a hormone. Furthermore, the beta A subunit forms a homodimer, activin A, and also joins with a beta B subunit to form a heterodimer, activin AB, both of which stimulate FSH secretion. (from LocusLink) ( NCI )] (UMLS (NCI) C0532964) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 1011. Activated Leukocyte Cell Adhesion Molecule
- [ALCAM is a cell adhesion molecule expressed on mitogen-activated leukocytes and monocytes, fibroblasts, neurons, and tumor-derived cell lines but not on unactivated leukocytes. ALCAM is a ligand for CD6, a receptor expressed on T-cells involved in cell adhesion interactions between thymocytes and thymic epithelial cells. ALCAM/CD6 interactions may play a role in the binding of T- and B-cells to activated leukocytes. ALCAM has five Ig domains and its amino acid sequence has significant homology to chicken neural adhesion molecule BEN/SC-1/DM-GRASP. (from OMIM 601662 and NCI) ( NCI )] (UMLS (NCI) C0295967) =Amino Acid, Peptide, or Protein; Carbohydrate; Immunologic Factor
| - 1061. Activin A Receptor Type II-Like 1
- [Activin A receptor, type II-like 1 (also called activin receptor-like kinase 1) is a type I cell-surface receptor for the TGF-beta superfamily of ligands. It shares with other type I receptors a high degree of similarity in serine-threonine kinase subdomains, a glycine- and serine-rich region (called the GS domain) preceding the kinase domain, and a short C-terminal tail. The ACVRL1 gene encodes a protein that shares similar domain structures with 3 other closely related ALK proteins (ALK2, ALK3, and ALK4) that together form a subfamily of receptor serine/threonine kinases. ACVRL1 is most highly expressed in human placenta and lung. ACVRL1 deficiency causes hemorrhagic telangiectasia type 2 (HHT2) also known as Rendu-Osler-Weber syndrome 2 (ORW2). ( NCI )] (UMLS (NCI) C0380146) =Amino Acid, Peptide, or Protein; Enzyme
|
- 1012. Activated Leukocyte Cell Adhesion Molecule Gene
- [This gene plays a role in cellular adhesion events involving immune cells, such as monocytes and leukocytes. ( NCI )] (UMLS (NCI) C1332075) ALCAM;
ALCAM Gene;
=Gene or Genome | - 1062. Activin A Receptor Type II-Like Kinase 53kDa
- [Expressed in all tissues (most in placenta) by human TGFBR1 Gene (TGFBR Ser/Thr Family), 503-aa 53-kDa (56-kDa precursor) Transforming Growth Factor Beta Receptor I is a type I transmembrane protein receptor for multifunctional cytokine TGFB1 containing a signal peptide, an extracellular Cys-rich region with an N-glycosylation site, a transmembrane region, and a cytoplasmic protein Ser/Thr kinase domain that mediates induction of cell-matrix adhesion genes and regulates cell cycle progression. TGF-beta binds either TGFBR1 or transmembrane Ser/Thr TGF-Beta II receptor, which form an active heterodimeric complex. TGFB stimulation leads to phosphorylation and activation of SMAD2 and SMAD3, which, complexed with SMAD4, accumulate in the nucleus and regulate transcription of target genes. Continuous SMAD nucleocytoplasmic shuttling during TGFB signaling monitors receptor activity. (NCI) ( NCI )] (UMLS (NCI) C0292688) =Amino Acid, Peptide, or Protein; Enzyme
|
- 1013. Activated Partial Thromboplastin Time
- [A measurement of the length of time that it takes for clotting to occur when reagents are added to a plasma specimen. The test is partial due to the absence of tissue factor (Factor III) from the reaction mixture. ( NCI )] (UMLS (NCI) C0030605) =Laboratory Procedure ;
| - 1063. Activin A Receptor, Type I
- [Activins are dimeric growth and differentiation factors that belong to the TGF-beta superfamily of signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases that include at least two type I (I and IB) and two type II (II and IIB) receptors. These receptors are all transmembrane proteins composed of a ligand-binding extracellular domain with cysteine-rich region, a transmembrane domain, and a cytoplasmic domain with predicted serine/threonine specificity. Type I receptors are essential for signaling and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Encoded by human ACVR1 Gene, Activin A Receptor Type I signals a particular transcriptional response in concert with activin type II receptors. (LocusLink) ( NCI )] (UMLS (NCI) C1447968) Activin A Receptor, Type II-Like Kinase 2;
ACVR1;
EC 2.7.1.37;
Hydroxyalkyl-Protein Kinase =Amino Acid, Peptide, or Protein; Enzyme; Receptor |
- 1014. Activated RNA Polymerase II Transcription Cofactor 4
- [Activated RNA Polymerase II Transcription Cofactor 4, encoded by the PC4 gene, is a general transcriptional coactivator for RNA polymerase II. This protein mediates transcriptional activation of class II genes. It is a single-stranded DNA-binding protein that functions through its interaction with TAFs. (from OMIM, LocusLink) ( NCI )] (UMLS (NCI) C0292779) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1064. Activin A Receptor, Type IB Gene
- [This gene plays a role in the transforming growth factor-beta signal transduction pathway. The gene also plays a role in the regulation of cellular growth, differentiation and signal transduction. ( NCI )] (UMLS (NCI) C1332011) ACVR1B;
ACVR1B Gene;
=Gene or Genome ;
|
- 1015. Activating Enhancer-Binding Protein 2 Beta
- [A transcription factor that belongs to the AP-2 family and binds viral and cellular enhancers containing the consensus 5'-GCCNNNGGC-3' DNA motif. AP-2 Beta appears to regulate expression of genes required for ectodermal development and retinoic acid-induced differentiation of neuroectodermal cells. (from SWISS-PROT Q92481, OMIM 601601, and NCI) ( NCI )] (UMLS (NCI) C1456736) AP-2 Beta;
AP-2 Transcription Factor Beta;
AP2-Beta;
TFAP2B;
TFAP2B Protein;
Transcription Factor AP-2 Beta;
Transcription Factor AP2-Beta;
=Amino Acid, Peptide, or Protein; Biologically Active Substance | - 1065. Activin A Receptor, Type II-Like Kinase 1 Gene
- [This gene is involved in the mediation of cell-surface receptor interactions for the TGF-beta superfamily of ligands. ( NCI )] (UMLS (NCI) C1366767) ACVRL1;
ACVRL1 Gene =Gene or Genome ;
|
- 1016. Activating Enhancer-Binding Protein 2 Gamma
- [A transcription factor that belongs to the AP-2 family and binds viral and cellular enhancers containing the consensus 5'-GCCNNNGGC-3' DNA motif. AP-2 Gamma appears to regulate expression of genes required for ectodermal development. (from SWISS-PROT Q92754, OMIM 601602, and NCI) ( NCI )] (UMLS (NCI) C0753144) AP-2 Gamma;
AP-2 Transcription Factor Gamma;
AP2-Gamma;
ERF1;
Estrogen Receptor Factor 1;
TFAP2C;
Transcription Factor AP-2 Gamma;
Transcription Factor ERF-1 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1066. Activin A Receptor, Type II-Like Kinase 4
- [Expressed in kidney, pancreas, brain, lung, and liver and encoded by human ACVR1B Gene (TGFBR Family), 505-aa 57-kD Activin A Type IB Receptor (isoforms A, B, and C) is a type I membrane protein with intracellular Ser/Thr kinase domain. Isoform A contains a complete kinase domain; B and C have truncated kinase domains and distinct C-termini. Activins signal through a transmembrane heteromeric complex of type I and type II receptors that all contain a ligand-binding extracellular domain with a cysteine-rich region. Type I receptors are essential for signaling and type II receptors are required for binding ligand. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. ( NCI )] (UMLS (NCI) C0663443) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
|
- 1017. Activating Enhancer-Binding Protein 2-Alpha
- [A 52-kDa, positive DNA-binding transcription factor that interacts with viral and cellular enhancers. AP-2 appears to regulate ectodermal development. ( NCI )] (UMLS (NCI) C0968902) Activator Protein 2;
AP2;
AP-2;
AP-2 Alpha;
AP-2 Alpha Protein;
AP2 Protein;
AP2 Transcription Factor;
AP2TF Protein;
TFAP2 Protein;
TFAP2A;
TFAP2A Protein;
Transcription Factor AP-2 Alpha =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1067. Activin A Receptor, Type IIB Gene
- [This gene plays a role in the transforming growth factor-beta signal transduction pathway and is essential for ligand binding and kinase activity. ( NCI )] (UMLS (NCI) C1332013) ACVR2B;
ACVR2B Gene;
=Gene or Genome ;
|
- 1018. Activating Signal Cointegrator-2
- [Encoded by human NCOA6 Gene, ubiquitous 2063-aa 250-kDa mono-/homodimeric Nuclear Receptor Coactivator 6 is a general and nuclear receptor transcriptional coactivator of the ASCOM complex containing two LXXLL motifs (the first mediates ligand-dependent interaction with receptor AF2 domains). NCOA6 directly binds prostanoid, retinoid, vitamin D3, thyroid hormone, and steroid receptors, to strongly enhance transcription in a ligand-/AF2-dependent manner. NCOA6 also appears to interact with RNPC2, NCOA1, CRSP3, RBM14, histone acetyltransferases EP300 and CREBBP, methyltransferases NCOA6IP and HRMT1L1/PRMT2, and with basal transcription factors GTF2A and TBP. Phosphorylated by PRKDC, NCOA6 may coactivate expression via chromatin remodeling and interaction with histone acetyltransferases. It may be involved in coactivation of the NF-kappa-B pathway. (NCI) ( NCI )] (UMLS (NCI) C0915178) AIB3;
Amplified in Breast Cancer-3 Protein;
ASC2;
Cancer-Amplified Transcriptional Coactivator ASC-2;
NCOA6;
NRC;
Nuclear Receptor Coactivator 6;
Nuclear Receptor Coactivator RAP250;
Nuclear Receptor-Activating Protein 250 kDa;
Peroxisome Proliferator-Activated Receptor Interacting Protein;
PPAR-Interacting Protein;
PRIP;
RAP250;
Thyroid Hormone Receptor Binding Protein;
TRBP;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1068. Activin A Type II Receptor
- [Activins are dimeric growth and differentiation factors which belong to the transforming growth factor-beta (TGF-beta) superfamily of structurally related signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. Activin A type II receptor, encoded by the ACVR2 gene, is a receptor for activin A, activin B, and activin C and constitutively active kinase. Type I receptors are essential for transmembrane signaling and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. (From LocusLink, OMIM and NCI) ( NCI )] (UMLS (NCI) C0754834) ACTR-II;
ACTRIIA;
ACVR2 =Amino Acid, Peptide, or Protein; Enzyme; Receptor |
- 1019. activating transcription factor
- [Activating transcription factors were originally identified as DNA-BINDING PROTEINS that interact with EARLY PROMOTERS from ADENOVIRUSES. They are a family of basic leucine zipper transcription factors that bind to the consensus site TGACGTCA of the cyclic AMP response element, and are closely related to CYCLIC AMP-RESPONSIVE DNA-BINDING PROTEIN. ( MSH )] (UMLS (CSP) C1148798) ATF =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1069. Activin A Type IIB Receptor
- [Activins are dimeric growth and differentiation factors that belong to the TGF-beta superfamily of signaling proteins. Activins signal through a heteromeric complex of receptor serine kinases which include at least two type I (I and IB) and two type II (II and IIB) receptors. Type I receptors are essential for signaling and type II receptors are required for binding ligands and for expression of type I receptors. Type I and II receptors form a stable complex after ligand binding, resulting in phosphorylation of type I receptors by type II receptors. Activin A type IIB receptor, encoded by the ACVR2 gene and a receptor for activin A, activin B, and activin C, displays a 3- to 4-fold higher affinity for the ligand than activin A type II receptor. (From LocusLink, Swiss_Prot) ( NCI )] (UMLS (NCI) C0246504) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
|
- 1020. Activating Transcription Factor 2
- [ATF proteins have been reported to be able to bind with FOS proteins to form the AP-1 transcription factor (from Nature Cell Biol. 4: E131-E136, 2002 via OMIM) ( NCI )] (UMLS (NCI) C1141625) ATF2;
CREB2;
CRE-Binding Protein 1;
CRE-BP1;
Cyclic AMP Response Element Binding Protein A;
HB16;
TREB7 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1070. Activin AB Beta
- [The inhibin beta B subunit joins the alpha subunit to form a pituitary FSH secretion inhibitor. Inhibin has been shown to regulate gonadal stromal cell proliferation negatively and to have tumor-suppressor activity. In addition, serum levels of inhibin have been shown to reflect the size of granulosa-cell tumors and can therefore be used as a marker for primary as well as recurrent disease. Because expression in gonadal and various extragonadal tissues may vary severalfold in a tissue-specific fashion, it is proposed that inhibin may be both a growth/differentiation factor and a hormone. Furthermore, the beta B subunit forms a homodimer, activin B, and also joins with the beta A subunit to form a heterodimer, activin AB, both of which stimulate FSH secretion. (LocusLink) ( NCI )] (UMLS (NCI) C1447906) Beta-2 Inhibin;
INHBB;
Inhibin Beta B;
Inhibin Beta-2 =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 1021. Activating Transcription Factor 2 Gene
- [This gene plays a role in transcriptional regulation and histone acetylation. ( NCI )] (UMLS (NCI) C1332119) ATF2;
ATF2 Gene =Gene or Genome ;
| - 1071. activin binding protein
- [activin-binding protein which inhibits the action of activin, and thereby inhibits the release of follicle stimulating hormone. ( CSP )] (UMLS (CSP) C0060623) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Folliculostatin;
binding protein |
- 1022. activation analysis
- [chemical analytic method based on the detection of characteristic radionuclides following a nuclear bombardment. ( CSP )] (UMLS (CSP) C0001282) =Laboratory Procedure ;
| - 1072. activin receptor
- [Receptors for ACTIVINS are membrane protein kinases belonging to the family of PROTEIN-SERINE-THREONINE KINASES, thus also named activin receptor-like kinases (ALK's). Activin receptors also bind TRANSFORMING GROWTH FACTOR BETA. As those transmembrane receptors of the TGF-beta superfamily (RECEPTORS, TRANSFORMING GROWTH FACTOR BETA), ALK's consist of two different but related protein kinases, Type I and Type II. Activins initiate cellular signal transduction by first binding to the type II receptors (ACTIVIN RECEPTORS, TYPE II ) which then recruit and phosphorylate the type I receptors (ACTIVIN RECEPTORS, TYPE I ) with subsequent activation of the type I kinase activity. ( MSH )] (UMLS (CSP) C0101389) =Amino Acid, Peptide, or Protein; Enzyme; Receptor
|
- 1023. activation of latent virus
- [ ] (UMLS (CSP) C0599617) =Disease or Syndrome
| - 1073. Activity
- [An action taken in pursuit of an objective; the state of being active. ( NCI )] (UMLS (NCI) C0441655) =Activity
|
- 1024. activation product
- [initiation of the intrinsic pathway of coagulation through interaction of coagulation factor XII with various electronegative surfaces, such as collagen fibers, skin, or sebum in vivo, or particulate silicates in vitro. ( CSP )] (UMLS (CSP) C0596035) =Amino Acid, Peptide, or Protein; Biologically Active Substance =Blood Coagulation Factor;
| - 1074. activity of daily living
- [physical, mental, or social ability to carry on the normal activities of life. ( CSP )] (UMLS (CSP) C0001288) =Daily or Recreational Activity ;
|
- 1025. Activator of Apoptosis HRK
- [Hrk is a protein promoting cell death by apoptosis. Hrk physically interacts with the survival-promoting proteins bcl-2 and bcl-xL, which also block cell death induced by expression of Hrk. Hrk does not interact with death-promoting proteins Bax or Bak. ( NCI )] (UMLS (NCI) C0538571) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1075. ActListCode
- [Provides codes associated with ActClass value of LIST (working list) ( HL7V3.0 )] (UMLS (HL7) C1697936) =Intellectual Product =HL7DefinedActCodes;
=medication list;
ActObservationList;
ActTherapyDurationWorkingListCode;
|
- 1026. Activator of S Phase Kinase
- [The G1/S transition in eukaryotic cells is strictly regulated so that DNA replication occurs only once during S phase. The CDC7L1 kinase complex may trigger S phase by directly activating the replication initiation complexes assembled at the origins. Phosphorylation of MCM2 and MCM3 in the MCM complex by the CDC7L1 kinase complex converts the inactive MCM complex into an active helicase. Activator of S Phase Kinase, encoded by the ASK gene, is a cyclin-like regulatory subunit of the CDC7L1 kinase complex. This protein is the major activator of CDC7L1. ASK plays a pivotal role in the G1/S transition in mammalian cells and its function is essential for entry into S phase. ASK interacts with CDC7L1 and stimulates the kinase activity of CDC7L1. CDC7L1-dependent kinase activity reflects the ASK protein level, significantly increasing in cells in S phase, and ASK protein is extensively phosphorylated during S phase, presumably by CDC7L1. ( NCI )] (UMLS (NCI) C1172410) ASK;
DBF4 Homolog;
Dumbbell Former 4 Homolog;
=Amino Acid, Peptide, or Protein; Biologically Active Substance ;
| - 1076. ActMedicalServiceCode
- [General category of medical service provided to the patient during their encounter. ( HL7V3.0 )] (UMLS (HL7) C1698550) =Intellectual Product =ActEncounterCode;
=Physical Rehab;
Obstetrics;
General;
Pharmaceutical;
Surgical;
Palliative;
Chronic;
Drug Rehab;
Oncology;
Alternative Level of Care;
Pediatrics;
Cardiology;
Dental;
Medical;
Psychiatric |
- 1027. Activator Protein 1
- [multiprotein complex composed of the products of c jun and c fos protooncogenes which must first dimerize in order to bind to the AP1 recognition site; it also controls both basal and inducible transcription of several genes. ( CSP )] (UMLS (NCI) C0085828) =Amino Acid, Peptide, or Protein; Biologically Active Substance =transcription factor;
| - 1077. ActMonitoringProtocolCode
- [Identifies types of monitoring programs ( HL7V3.0 )] (UMLS (HL7) C1697937) =Intellectual Product =HL7DefinedActCodes;
=Controlled Substance;
|
- 1028. Activator Protein 2 Gene
- [Human transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) (TFAP2A) gene, located at 6p24, encodes transcription factor AP-2 alpha. This gene is developmentally regulated and expression is induced by retinoic acid. Alternative splicing of the AP2 gene produces four mRNA transcripts, resulting in four protein isoforms. One of these proteins is a negative regulator of transcriptional activation by AP-2. ( NCI )] (UMLS (NCI) C0812205) Oncogene AP2 =Gene or Genome
| - 1078. ActMood
- (UMLS (HL7) C1553724) =Intellectual Product =CodeSystem;
=recommendation;
risk;
expectancy;
permission;
permission request;
ActMoodCompletionTrack;
ActMoodPredicate;
|
- 1029. Activator-Recruited Cofactor 33 kDa Component
- [Encoded by human MED6 Gene (MED6 Family), 246-aa 28-kDa nuclear Mediator of RNA Polymerase II Transcription Subunit 6 Homolog is a coactivation component of transcriptional mediator complexes involved in transcriptional activation and repression. Transcription requires intermediary proteins that transduce signals from regulatory activator proteins to the basal transcription machinery at the core promoter. Physically associated with RNA polymerase II and essential for transcriptional activation, MED6 appears required for transcriptional activation of most of the RNA polymerase II-transcribed genes and not to be involved in uninduced or repressed transcription, transcription of constitutively expressed genes, or transcription by RNA polymerases I or III. MED6 is a subunit of the multiprotein ARC/DRIP and CRSP complexes. (NCI) ( NCI )] (UMLS (NCI) C1334500) ARC33;
MED6 Homolog;
Mediator of RNA Polymerase II Transcription Subunit 6 Homolog;
NY-REN-28 Antigen;
RNA Polymerase II Transcriptional Regulation Mediator =Amino Acid, Peptide, or Protein; Biologically Active Substance | - 1079. ActMoodCompletionTrack
- [These are moods describing activities as they progress in the business cycle, from defined, through planned and ordered to completed. ( HL7V3.0 )] (UMLS (HL7) C1699124) =Functional Concept ;
=ActMood;
=definition;
intent;
event (occurrence);
|
- 1030. Active
- (UMLS (HL7) C1561512) =Idea or Concept =Document Storage Status;
◊ (UMLS (HL7) C1561513) Idea or Concept Immunization Registry Status; | - 1080. ActMoodPredicate
- [Any of the above service moods (e.g., event, intent, or goal) can be turned into a predicate used as a criterion to express conditionals (or queries.) However, currently we allow only criteria on service events. ( HL7V3.0 )] (UMLS (HL7) C1699125) =Functional Concept ;
=ActMood;
=event criterion;
option;
Goal;
|
- 1031. active
- [The Act can be performed or is being performed ( HL7V3.0 )] (UMLS (HL7) C1547419) =Idea or Concept =normal;
| - 1081. ActNoImmunizationReason
- [ A coded description of the reason for why a patient did not receive a scheduled immunization.(important for public health strategy ( HL7V3.0 )] (UMLS (HL7) C1699089) =Intellectual Product =ActReason;
|
- 1032. Active
- [Concept code is active and in use ( HL7V3.0 )] (UMLS (HL7) C1553875) =Idea or Concept =HL7 Coded Concept Status;
◊ [The item has been reviewed and approved and is now valid for use in HL7 standards and messages. ( HL7V3.0 )] (UMLS (HL7) C1561507) Idea or Concept EditStatus; | - 1082. actobindin
- [ ] (UMLS (CSP) C0050669) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 1033. active
- [The state representing the fact that the Participation is in progress. ( HL7V3.0 )] (UMLS (HL7) C1561508) =Idea or Concept =normal;
◊ [The state representing the fact that the Entity is currently active in the Role. ( HL7V3.0 )] (UMLS (HL7) C1561509) Idea or Concept normal; ◊ [The state representing the fact that the Entity record is currently active. ( HL7V3.0 )] (UMLS (HL7) C1561510) Idea or Concept normal; ◊ [A storage status in which a document is available on-line. ( HL7V3.0 )] (UMLS (HL7) C1561511) Idea or Concept DocumentStorage; Active and archived | - 1083. ActObservationList
- (UMLS (HL7) C1699294) =Intellectual Product ;
=ActListCode;
=condition list;
goal list;
care plan |
- 1034. Active
- [Exerting influence or producing an effect; taking part in an activity. ( NCI )] (UMLS (NCI) C0205177) =Functional Concept
| - 1084. actomyosin
- [A protein complex of actin and MYOSINS occurring in muscle. It is the essential contractile substance of muscle. ( MSH )] (UMLS (CSP) C0001291) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 1035. Active and archived
- [A storage status in which a document is available on-line and is also stored off-line for long-term access. ( HL7V3.0 )] (UMLS (HL7) C1548397) =Idea or Concept =Document Storage Status;
active | - 1085. actomyosin ATPase
- [ ] (UMLS (CSP) C0001478) =Amino Acid, Peptide, or Protein; Enzyme ;
|
- 1036. Active brilliant orange KH stain
- [Stain, Active brilliant orange KH ( HL7V3.0 )] (UMLS (HL7) C1293986) =Laboratory Procedure =ObservationMethod;
| - 1086. Actonel
- (UMLS (NCI) C0718248) Actonel brand of risedronate sodium =Organic Chemical; Pharmacologic Substance ;
|
- 1037. Active Caries
- [Tooth decay that is increasing in size or scope. ( NCI )] (UMLS (NCI) C0429170) =Finding
| - 1087. actophorin
- [ ] (UMLS (CSP) C0050671) =Amino Acid, Peptide, or Protein; Biologically Active Substance
|
- 1038. Active duty
- (UMLS (HL7) C1549463) =Idea or Concept =Military Status;
| - 1088. ActOrderCode
- [The type of order that was fulfilled by the clinical service ( HL7V3.0 )] (UMLS (HL7) C1698551) =Intellectual Product =HL7DefinedActCodes;
|
- 1039. Active Immunization
- [immunity that results from the response of the immune system to an injection of antigen. ( CSP )] (UMLS (NCI) C0205991) =Therapeutic or Preventive Procedure ;
=immunization;
| - 1089. ActPatientTransportationModeCode
- [ Definition: Characterizes how a patient was or will be transported to the site of a patient encounter. Examples: Via ambulance, via public transit, on foot. ( HL7V3.0 )] (UMLS (HL7) C1699600) =Intellectual Product ;
=ActCode;
=ambulance transport;
private transport;
public transport;
law enforcement transport;
pedestrian transport |
- 1040. active ingredient
- [A therapeutically active ingredient (player) in a mixture (scoper), where the mixture is typically a manufactured pharmaceutical. ( HL7V3.0 )] (UMLS (HL7) C1372955) Active Ingredients =Pharmacologic Substance ;
=National Drug File - Reference Terminology;
ingredient =Amino Acids, Peptides, and Proteins;
Biomedical and Dental Materials;
Carbohydrates and Hypoglycemic Agents;
Growth Substances, Pigments, and Vitamins;
Heterocyclic Compound;
Inorganic Chemical;
Nucleic Acids, Nucleosides, and Nucleotides;
Organic Chemical;
carbopolycyclic compound;
Unclassified Ingredients;
Lipids and Antilipemic Agents;
Enzymes, Coenzymes, and Enzyme Inhibitors;
| - 1090. ActPaymentCode
- [Code identifying the method or the movement of payment instructions. Codes are drawn from X12 data element 591 (PaymentMethodCode) ( HL7V3.0 )] (UMLS (HL7) C1699118) =Intellectual Product ;
=HL7DefinedActCodes;
=Automated Clearing House;
Cheque;
Direct Deposit;
Non-Payment Data |
- 1041. Active Inpatient
- (UMLS (HL7) C1546842) =Intellectual Product =Patient Status Code;
| - 1091. ActPharmacySupplyType
- [Identifies types of dispensing events ( HL7V3.0 )] (UMLS (HL7) C1699636) =Intellectual Product ;
=HL7DefinedActCodes;
=First Fill;
Refill;
Manufacturer Sample;
Emergency Supply;
Floor stock |
- 1042. Active Meniere's disease, cochlear
- (UMLS (ICD9CM) C0155497) =Disease or Syndrome ;
| - 1092. ActPriority
- (UMLS (HL7) C1553836) =Intellectual Product =CodeSystem;
=emergency;
Immediate;
Routine;
use as directed;
ASAP;
preop;
callback for scheduling;
timing critical;
as needed;
callback results;
Rush reporting;
elective;
urgent;
|
- 1043. Active Meniere's disease, cochleovestibular
- (UMLS (ICD9CM) C0155496) =Disease or Syndrome ;
| - 1093. ActPrivilegeCategorization
- [An Act which characterizes a Privilege can have additional observations to provide a finer definition of the requested or conferred privilege. This domain describes the categories under which this additional information is classified. ( HL7V3.0 )] (UMLS (HL7) C1699596) =Classification ;
=ActCode;
|
- 1044. Active Meniere's disease, vestibular
- (UMLS (ICD9CM) C0155498) =Disease or Syndrome ;
| - 1094. ActPrivilegeCategorizationType
- [This domain includes observations used to characterize a privilege, under which this additional information is classified. Examples:A privilege to prescribe drugs has a RESTRICTION that excludes prescribing narcotics; a surgical procedure privilege has a PRE-CONDITION that it requires prior Board approval. ( HL7V3.0 )] (UMLS (HL7) C1699131) =Intellectual Product ;
=ActCode;
|
- 1045. Active Methionine
- (UMLS (NCI) C0684182) =Amino Acid, Peptide, or Protein; Biologically Active Substance
| - 1095. ActProcedureCode
- [An identifying code for healthcare interventions/procedures. ( HL7V3.0 )] (UMLS (HL7) C1698584) =Intellectual Product ;
=HL7DefinedActCodes;
|
- 1046. active moiety
- [The molecule or ion that is responsible for the intended pharmacological action of the drug substance, excluding those appended or associated parts of the molecule that make the molecule an ester, salt (including a salt with hydrogen or coordination bonds), or other noncovalent derivative (such as a complex, chelate, or clathrate).Examples: heparin-sodium and heparin-potassium have the same active moiety, heparin; the active moiety of morphine-hydrochloride is morphine. ( HL7V3.0 )] (UMLS (HL7) C1552018) =Chemical Viewed Functionally =ingredient;
| - 1096. ActProductAcquisitionCode
- [The method that a product is obtained for use by the subject of the supply act (e.g. patient). Product examples are consumable or durable goods. ( HL7V3.0 )] (UMLS (HL7) C1699119) =Intellectual Product ;
=HL7DefinedActCodes;
=Transfer;
Loan |
- 1047. active sensitization
- [ ] (UMLS (CSP) C0597749) =Therapeutic or Preventive Procedure ;
| - 1097. ACTR
- [NCOA3 is a nuclear receptor coactivator that directly binds nuclear receptors and stimulates the transcriptional activities in hormone-dependent fashion. NCOA3 recruits 2 other nuclear factors, CBP and PCAF, and thus plays a central role in creating a multisubunit coactivator complex. (LocusLink) ( NCI )] (UMLS (NCI) C0663204) =Amino Acid, Peptide, or Protein; Biologically Active Substance ;
|
- 1048. active site
- [molecular location on an enzyme where substrate binds and catalysis occurs. ( CSP )] (UMLS (CSP) C0205681) =Functional Concept ;
=enzyme structure;
molecular site | - 1098. ActReason
- (UMLS (HL7) C1553844) =Intellectual Product =CodeSystem;
=scheduled;
non-protocol;
Retired Code;
Retired Code;
Retired Code;
Retired Code;
Retired Code;
Retired Code;
Retired Code;
termination;
ReasonForNotEvaluatingDevice;
ActAccommodationReason;
ActAdjudicationReason;
ActBillableClinicalServiceReason;
ActIneligibilityReason;
TransferActReason;
retest;
per protocol;
ControlActReason;
ControlActReasonConditionNullify;
SubstanceAdminSubstitutionReason;
ActNoImmunizationReason;
ActSupplyFulfillmentRefusalReason;
SubstanceAdminSubstitutionNotAllowedReason;
ReferralReasonCode;
ActInvoiceCancelReason;
EligibilityActReasonCode;
NonPerformanceReasonCode;
SchedulingActReason;
unscheduled;
per definition |
- 1049. Active Staff
- (UMLS (HL7) C1549613) =Idea or Concept =Active/Inactive;
| - 1099. ActRegistryCode
- [This is the domain of registry types. Examples include Master Patient Registry, Staff Registry, Employee Registry, Tumor Registry. ( HL7V3.0 )] (UMLS (HL7) C1699637) =Intellectual Product ;
=HL7DefinedActCodes;
|
- 1050. Active Surveillance
- [The most conservative option for patient under the control of medical professional. The concept refers to the situation when patient's condition is closely monitored under assigned "precaution" level, but treatment is withheld until signs or symptoms of the disease appear or change. ( NCI )] (UMLS (NCI) C0700325) =Therapeutic or Preventive Procedure
| - 1100. ActRelationshipAccounting
- [Codes that describe the relationship between an Act and a financial instrument such as a financial transaction, account or invoice element. ( HL7V3.0 )] (UMLS (HL7) C1698639) =Qualitative Concept =has pertinent information;
=ActRelationshipCostTracking;
ActRelationshipPosting;
ActRelationshipCostTracking;
ActRelationshipPosting;
|
home
